Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 15.194% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CC(=O)N1c2ccccc2C(C)CC12CCCCC2
b.) CCC(C)[C@H](NC(=O)N1CCC(Cc2ccccc2)CC1)C(=O)O
Answer: b. CCC(C)[C@H](NC(=O)N1CCC(Cc2ccccc2)CC1)C(=O)O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)[C@H](NC(=O)N1CCC(Cc2ccccc2)CC1)C(=O)O
CCC(C)[C@H](NC(=O)N1CCC(Cc2ccccc2)CC1)C(=O)O
(2S)-2-[(4-benzylpiperidine-1-carbonyl)amino]-3-methylpentanoic acid